Horseradish Peroxidase (HRP) Market By Substrate (Chromogenic, Chemiluminescent, Others) , By Application (Immunoassays, Biosensors) By End User (Diagnostic Centers, Biopharmaceutical Companies, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Horseradish Peroxidase (HRP) Market
The horseradish peroxidase (HRP) market was valued at $59.1 million in 2023 and is projected to reach $115.2 million by 2033, growing at a CAGR of 6.9% from 2024 to 2033.
Horseradish peroxidase (HRP) is a glycoprotein extracted from horseradish, a root vegetable. It is a heme group-containing enzyme used for the catalysis of oxidative reactions. The enzyme finds applications in several immunoassays as it generates a luminescent derivative upon infusion with an appropriate substrate. Hence, detection and quantification are the key attributes of HRP.
Expansion of the biotechnology and diagnostics industry has upsurged the requirement for HRP, propelling the development of the market. In addition, innovations in medical R&D have augmented the horseradish peroxidase (HRP) market as the enzyme is significantly being incorporated into biosensors and drug development procedures. Furthermore, expansion of the precision medicine landscape drives the market growth as several tests and assays are conducted for the development of personalized treatments for individuals. In recent times, explorations regarding the modification of HRP to amplify its potential and applications are trending in the market. Scientists are creating mimic enzymes with the ability to bind to nanomaterials & polymers to examine and intensify the catalytic activity & stability of HRP. These explorations are expected to extend the applicability of the enzyme in the life sciences industry.
However, the quick reaction time of HRP restricts its utility across applications with extended reaction times, hindering the development of the market. Moreover, sensitivity of HRP toward light deters several researchers from utilizing it as a potential enzyme for chemical reactions and assays. Hence, the light-sensitive nature of HRP hampers the market growth notably. On the contrary, as the popularity of portable diagnostic kits is increasing, the horseradish peroxidase (HRP) market is witnessing several lucrative opportunities. Several research facilities and healthcare firms are focusing on the development of rapid diagnostic kits for the detection of different diseases & health conditions, hence opening new avenues for the market.
Segment Review
The horseradish peroxidase (HRP) market is segmented into substrate, application, end user, and region. On the basis of substrate, the market is divided into chromogenic, chemiluminescent, and others. Depending on application, it is bifurcated into immunoassays and biosensors. According to end user, it is classified into diagnostic centers, biopharmaceutical companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of substrate, the chromogenic segment held a high share of the market in 2023.
Depending on application, the immunoassays segment dominated the market in 2023.
According to end user, the biopharmaceutical companies segment is projected to account for a high market share during the forecast period.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The leading players operating in the global horseradish peroxidase (HRP) market include Abcam Limited, Abnova Corporation, BBI Solutions, Bio-Rad Laboratories, Inc., Creative Enzymes, Enzo Life Sciences, Inc., F. Hoffman-La Roche Ltd., Faizyme Laboratories (Pty) Ltd., GenScript, and Merck KGaA. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Key Market Segments
By Substrate
Chromogenic
Chemiluminescent
Others
By Application
Immunoassays
Biosensors
By End User
Diagnostic Centers
Biopharmaceutical Companies
Others
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Abcam Limited
Abnova Corporation
BBI Solutions
Bio-Rad Laboratories, Inc.
Creative Enzymes
Enzo Life Sciences, Inc.
F. Hoffman-La Roche Ltd.
Faizyme Laboratories (Pty) Ltd.
GenScript
Merck KGaA
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Substrate
- 4.2. Chromogenic
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Chemiluminescent
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Others
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Immunoassays
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Biosensors
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Diagnostic Centers
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Biopharmaceutical Companies
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: HORSERADISH PEROXIDASE (HRP) MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Substrate
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Horseradish Peroxidase (HRP) Market
- 7.2.6.1. Market Size and Forecast, By Substrate
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Horseradish Peroxidase (HRP) Market
- 7.2.7.1. Market Size and Forecast, By Substrate
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Horseradish Peroxidase (HRP) Market
- 7.2.8.1. Market Size and Forecast, By Substrate
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Substrate
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Horseradish Peroxidase (HRP) Market
- 7.3.6.1. Market Size and Forecast, By Substrate
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Horseradish Peroxidase (HRP) Market
- 7.3.7.1. Market Size and Forecast, By Substrate
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Horseradish Peroxidase (HRP) Market
- 7.3.8.1. Market Size and Forecast, By Substrate
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Horseradish Peroxidase (HRP) Market
- 7.3.9.1. Market Size and Forecast, By Substrate
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Horseradish Peroxidase (HRP) Market
- 7.3.10.1. Market Size and Forecast, By Substrate
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Horseradish Peroxidase (HRP) Market
- 7.3.11.1. Market Size and Forecast, By Substrate
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Substrate
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Horseradish Peroxidase (HRP) Market
- 7.4.6.1. Market Size and Forecast, By Substrate
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Horseradish Peroxidase (HRP) Market
- 7.4.7.1. Market Size and Forecast, By Substrate
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Horseradish Peroxidase (HRP) Market
- 7.4.8.1. Market Size and Forecast, By Substrate
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Horseradish Peroxidase (HRP) Market
- 7.4.9.1. Market Size and Forecast, By Substrate
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Horseradish Peroxidase (HRP) Market
- 7.4.10.1. Market Size and Forecast, By Substrate
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Horseradish Peroxidase (HRP) Market
- 7.4.11.1. Market Size and Forecast, By Substrate
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Substrate
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Horseradish Peroxidase (HRP) Market
- 7.5.6.1. Market Size and Forecast, By Substrate
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Horseradish Peroxidase (HRP) Market
- 7.5.7.1. Market Size and Forecast, By Substrate
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Horseradish Peroxidase (HRP) Market
- 7.5.8.1. Market Size and Forecast, By Substrate
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Horseradish Peroxidase (HRP) Market
- 7.5.9.1. Market Size and Forecast, By Substrate
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Abcam Limited
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Abnova Corporation
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. BBI Solutions
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Bio-Rad Laboratories, Inc.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Creative Enzymes
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Enzo Life Sciences, Inc.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. F. Hoffman-La Roche Ltd.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Faizyme Laboratories (Pty) Ltd.
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. GenScript
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Merck KGaA
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 2. HORSERADISH PEROXIDASE (HRP) MARKET FOR CHROMOGENIC, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 3. HORSERADISH PEROXIDASE (HRP) MARKET FOR CHEMILUMINESCENT, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 4. HORSERADISH PEROXIDASE (HRP) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 5. GLOBAL HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 6. HORSERADISH PEROXIDASE (HRP) MARKET FOR IMMUNOASSAYS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 7. HORSERADISH PEROXIDASE (HRP) MARKET FOR BIOSENSORS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 8. GLOBAL HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 9. HORSERADISH PEROXIDASE (HRP) MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 10. HORSERADISH PEROXIDASE (HRP) MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 11. HORSERADISH PEROXIDASE (HRP) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 12. HORSERADISH PEROXIDASE (HRP) MARKET, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 13. NORTH AMERICA HORSERADISH PEROXIDASE (HRP) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 14. NORTH AMERICA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 15. NORTH AMERICA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 16. NORTH AMERICA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 17. U.S. HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 18. U.S. HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 19. U.S. HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 20. CANADA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 21. CANADA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 22. CANADA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 23. MEXICO HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 24. MEXICO HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 25. MEXICO HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 26. EUROPE HORSERADISH PEROXIDASE (HRP) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 27. EUROPE HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 28. EUROPE HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 29. EUROPE HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 30. FRANCE HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 31. FRANCE HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 32. FRANCE HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 33. GERMANY HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 34. GERMANY HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 35. GERMANY HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 36. ITALY HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 37. ITALY HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 38. ITALY HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 39. SPAIN HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 40. SPAIN HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 41. SPAIN HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 42. UK HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 43. UK HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 44. UK HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 45. REST OF EUROPE HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 46. REST OF EUROPE HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 47. REST OF EUROPE HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 48. ASIA-PACIFIC HORSERADISH PEROXIDASE (HRP) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 49. ASIA-PACIFIC HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 50. ASIA-PACIFIC HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 51. ASIA-PACIFIC HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 52. CHINA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 53. CHINA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 54. CHINA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 55. JAPAN HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 56. JAPAN HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 57. JAPAN HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 58. INDIA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 59. INDIA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 60. INDIA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 61. SOUTH KOREA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 62. SOUTH KOREA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 63. SOUTH KOREA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 64. AUSTRALIA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 65. AUSTRALIA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 66. AUSTRALIA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 67. REST OF ASIA-PACIFIC HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 69. REST OF ASIA-PACIFIC HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 70. LAMEA HORSERADISH PEROXIDASE (HRP) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 71. LAMEA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 72. LAMEA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 73. LAMEA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 74. BRAZIL HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 75. BRAZIL HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 76. BRAZIL HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 77. SOUTH AFRICA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 78. SOUTH AFRICA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 79. SOUTH AFRICA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 80. SAUDI ARABIA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 81. SAUDI ARABIA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 82. SAUDI ARABIA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 83. REST OF LAMEA HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE, 2024 - 2033 ($MILLION)
- TABLE 84. REST OF LAMEA HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 85. REST OF LAMEA HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 86. ABCAM LIMITED: KEY EXECUTIVES
- TABLE 87. ABCAM LIMITED: COMPANY SNAPSHOT
- TABLE 88. ABCAM LIMITED: OPERATING SEGMENTS
- TABLE 89. ABCAM LIMITED: PRODUCT PORTFOLIO
- TABLE 90. ABCAM LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 91. ABNOVA CORPORATION: KEY EXECUTIVES
- TABLE 92. ABNOVA CORPORATION: COMPANY SNAPSHOT
- TABLE 93. ABNOVA CORPORATION: OPERATING SEGMENTS
- TABLE 94. ABNOVA CORPORATION: PRODUCT PORTFOLIO
- TABLE 95. ABNOVA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 96. BBI SOLUTIONS: KEY EXECUTIVES
- TABLE 97. BBI SOLUTIONS: COMPANY SNAPSHOT
- TABLE 98. BBI SOLUTIONS: OPERATING SEGMENTS
- TABLE 99. BBI SOLUTIONS: PRODUCT PORTFOLIO
- TABLE 100. BBI SOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 101. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES
- TABLE 102. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
- TABLE 103. BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
- TABLE 104. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
- TABLE 105. BIO-RAD LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 106. CREATIVE ENZYMES: KEY EXECUTIVES
- TABLE 107. CREATIVE ENZYMES: COMPANY SNAPSHOT
- TABLE 108. CREATIVE ENZYMES: OPERATING SEGMENTS
- TABLE 109. CREATIVE ENZYMES: PRODUCT PORTFOLIO
- TABLE 110. CREATIVE ENZYMES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 111. ENZO LIFE SCIENCES, INC.: KEY EXECUTIVES
- TABLE 112. ENZO LIFE SCIENCES, INC.: COMPANY SNAPSHOT
- TABLE 113. ENZO LIFE SCIENCES, INC.: OPERATING SEGMENTS
- TABLE 114. ENZO LIFE SCIENCES, INC.: PRODUCT PORTFOLIO
- TABLE 115. ENZO LIFE SCIENCES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 116. F. HOFFMAN-LA ROCHE LTD.: KEY EXECUTIVES
- TABLE 117. F. HOFFMAN-LA ROCHE LTD.: COMPANY SNAPSHOT
- TABLE 118. F. HOFFMAN-LA ROCHE LTD.: OPERATING SEGMENTS
- TABLE 119. F. HOFFMAN-LA ROCHE LTD.: PRODUCT PORTFOLIO
- TABLE 120. F. HOFFMAN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 121. FAIZYME LABORATORIES (PTY) LTD.: KEY EXECUTIVES
- TABLE 122. FAIZYME LABORATORIES (PTY) LTD.: COMPANY SNAPSHOT
- TABLE 123. FAIZYME LABORATORIES (PTY) LTD.: OPERATING SEGMENTS
- TABLE 124. FAIZYME LABORATORIES (PTY) LTD.: PRODUCT PORTFOLIO
- TABLE 125. FAIZYME LABORATORIES (PTY) LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 126. GENSCRIPT: KEY EXECUTIVES
- TABLE 127. GENSCRIPT: COMPANY SNAPSHOT
- TABLE 128. GENSCRIPT: OPERATING SEGMENTS
- TABLE 129. GENSCRIPT: PRODUCT PORTFOLIO
- TABLE 130. GENSCRIPT: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 131. MERCK KGAA: KEY EXECUTIVES
- TABLE 132. MERCK KGAA: COMPANY SNAPSHOT
- TABLE 133. MERCK KGAA: OPERATING SEGMENTS
- TABLE 134. MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 135. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL HORSERADISH PEROXIDASE (HRP) MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF HORSERADISH PEROXIDASE (HRP) MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN HORSERADISH PEROXIDASE (HRP) MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHORSERADISH PEROXIDASE (HRP) MARKET
- FIGURE 10. GLOBAL HORSERADISH PEROXIDASE (HRP) MARKET SEGMENTATION, BY SUBSTRATE
- FIGURE 11. HORSERADISH PEROXIDASE (HRP) MARKET FOR CHROMOGENIC, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 12. HORSERADISH PEROXIDASE (HRP) MARKET FOR CHEMILUMINESCENT, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 13. HORSERADISH PEROXIDASE (HRP) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 14. GLOBAL HORSERADISH PEROXIDASE (HRP) MARKET SEGMENTATION, BY APPLICATION
- FIGURE 15. HORSERADISH PEROXIDASE (HRP) MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 16. HORSERADISH PEROXIDASE (HRP) MARKET FOR BIOSENSORS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 17. GLOBAL HORSERADISH PEROXIDASE (HRP) MARKET SEGMENTATION, BY END USER
- FIGURE 18. HORSERADISH PEROXIDASE (HRP) MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 19. HORSERADISH PEROXIDASE (HRP) MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 20. HORSERADISH PEROXIDASE (HRP) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 25. COMPETITIVE DASHBOARD
- FIGURE 26. COMPETITIVE HEATMAP: HORSERADISH PEROXIDASE (HRP) MARKET
- FIGURE 27. TOP PLAYER POSITIONING, 2023
- FIGURE 28. ABCAM LIMITED: NET SALES, 2021-2023 ($MILLION)
- FIGURE 29. ABCAM LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 30. ABCAM LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 31. ABNOVA CORPORATION: NET SALES, 2021-2023 ($MILLION)
- FIGURE 32. ABNOVA CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. ABNOVA CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. BBI SOLUTIONS: NET SALES, 2021-2023 ($MILLION)
- FIGURE 35. BBI SOLUTIONS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. BBI SOLUTIONS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. BIO-RAD LABORATORIES, INC.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 38. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. CREATIVE ENZYMES: NET SALES, 2021-2023 ($MILLION)
- FIGURE 41. CREATIVE ENZYMES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. CREATIVE ENZYMES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. ENZO LIFE SCIENCES, INC.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 44. ENZO LIFE SCIENCES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. ENZO LIFE SCIENCES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. F. HOFFMAN-LA ROCHE LTD.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 47. F. HOFFMAN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. F. HOFFMAN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. FAIZYME LABORATORIES (PTY) LTD.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 50. FAIZYME LABORATORIES (PTY) LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. FAIZYME LABORATORIES (PTY) LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. GENSCRIPT: NET SALES, 2021-2023 ($MILLION)
- FIGURE 53. GENSCRIPT: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. GENSCRIPT: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. MERCK KGAA: NET SALES, 2021-2023 ($MILLION)
- FIGURE 56. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. MERCK KGAA: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook